1. Home
  2. VSTM vs TLS Comparison

VSTM vs TLS Comparison

Compare VSTM & TLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSTM
  • TLS
  • Stock Information
  • Founded
  • VSTM 2010
  • TLS 1969
  • Country
  • VSTM United States
  • TLS United States
  • Employees
  • VSTM N/A
  • TLS N/A
  • Industry
  • VSTM Biotechnology: Pharmaceutical Preparations
  • TLS EDP Services
  • Sector
  • VSTM Health Care
  • TLS Technology
  • Exchange
  • VSTM Nasdaq
  • TLS Nasdaq
  • Market Cap
  • VSTM 598.2M
  • TLS 508.2M
  • IPO Year
  • VSTM 2012
  • TLS 2020
  • Fundamental
  • Price
  • VSTM $8.94
  • TLS $7.41
  • Analyst Decision
  • VSTM Strong Buy
  • TLS Hold
  • Analyst Count
  • VSTM 9
  • TLS 4
  • Target Price
  • VSTM $13.38
  • TLS $4.83
  • AVG Volume (30 Days)
  • VSTM 1.7M
  • TLS 936.0K
  • Earning Date
  • VSTM 11-05-2025
  • TLS 11-11-2025
  • Dividend Yield
  • VSTM N/A
  • TLS N/A
  • EPS Growth
  • VSTM N/A
  • TLS N/A
  • EPS
  • VSTM N/A
  • TLS N/A
  • Revenue
  • VSTM $2,137,000.00
  • TLS $116,739,000.00
  • Revenue This Year
  • VSTM $88.50
  • TLS $47.80
  • Revenue Next Year
  • VSTM $398.66
  • TLS $26.19
  • P/E Ratio
  • VSTM N/A
  • TLS N/A
  • Revenue Growth
  • VSTM N/A
  • TLS N/A
  • 52 Week Low
  • VSTM $2.54
  • TLS $1.83
  • 52 Week High
  • VSTM $11.25
  • TLS $7.48
  • Technical
  • Relative Strength Index (RSI)
  • VSTM 53.26
  • TLS 63.67
  • Support Level
  • VSTM $8.49
  • TLS $6.73
  • Resistance Level
  • VSTM $9.14
  • TLS $7.27
  • Average True Range (ATR)
  • VSTM 0.43
  • TLS 0.37
  • MACD
  • VSTM -0.10
  • TLS -0.06
  • Stochastic Oscillator
  • VSTM 54.31
  • TLS 88.67

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

About TLS Telos Corporation

Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.

Share on Social Networks: